Lysophosphatidylcholine Decreases Delayed Rectifier K+ Current in Rabbit Coronary Smooth Muscle Cells

Journal of Veterinary Medical Science

Volumn 63, Issue 4, 2001, Pages 395-399

  Yeon, Dongsoo ^a   Kwon, Seongchun ^a   Nam, Taicksang ^a   Ahn, Ducksun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Coronary smooth muscle; Delayed rectifier K+ current; Lysophosphatidylcholine; Protein kinase C

Indexed keywords

ORYCTOLAGUS CUNICULUS;

ENZYME INHIBITOR; IBERIOTOXIN; LYSOPHOSPHATIDYLCHOLINE; PEPTIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN KINASE C; STAUROSPORINE;

ANIMAL; ARTICLE; CELL MEMBRANE POTENTIAL; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; PATCH CLAMP; PHYSIOLOGY; RABBIT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CORONARY VESSELS; DRUG ANTAGONISM; ENZYME INHIBITORS; LYSOPHOSPHATIDYLCHOLINES; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PROTEIN KINASE C; RABBITS; STAUROSPORINE;

EID: 0035316831     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.63.395     Document Type: Article

References (28)

1. + channels in canine pulmonary arterial smooth muscle cells. Pflugers. Arch. Eur. J. Physiol. 433: 758-765.
2. + channels by beta agonist in rabbit coronary smooth muscle cells. Yonsei Med. J. 36: 232-242.
3. + current in rabbit vascular smooth muscle cells. Am. J. Physiol. 271:H109-119.
4. 2+-dependent retraction of vascular smooth muscle cells. Circ. Res. 79: 871-880.
5. + current in canine colonic smooth muscle. J. Physiol. 484: 339-353.
6. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis 112: 69-76.
7. + channels in vascular smooth muscle by phosphorylation. Biochem. Cell Biol. 74 439-447.
8. Cox, D.A. and Cohen, M.L. 1996. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Pharmacol. Rev. 48. 3-19.
9. Cox, D.A. and Cohen, M.L. 1996. Selective enhancement of 5-hyroxytryptamine-induced contraction of porcine coronary artery by oxidized low density lipoprotein. J. Pharmacol. Exp. Ther. 216: 1095-1103.
10. Cox, R.H. and Tulenko, T.N. 1995. Altered contractile and ion channel function in rabbit portal vein with dietary atherosclerosis. Am. J Physiol. 268. H2522-H2530.
11. Eizawa, H., Yui, Y., Inoue, R., Kosuga, K., Hattori, R., Aoyama, T. and Sasayama, S. 1995. Lysophosphatidylcholine inhibits endothelium-dependent hyperpolarization and N-omega-nitro-L-arginine/indomethacin-resistant endothelium-dependent relaxation in the porcine coronary artery. Circulation 92: 3520-3526.
12. Epand, R.M. and Lester, D.S. 1990. The role of membrane biophysical properties in the regulation of protein kinase C activity. Trends. Pharmacol. Sci. 11: 317-320.
13. Galle, J., Bassenge, E. and Busse, R. 1990. Oxidized low density lipoproteins potentiate vasoconstriction to various agonists by direct interaction with vascular smooth muscle. Circ. Res. 66: 1287-1293
14. Herbert, J.M., Seban, E. and Maffrand, J.P. 1990. Characterization of specific binding sites for [3H]-staurosporine on various protein kinases. Biochem. Biophys. Res. Commun. 171: 189-195.
15. Jabr, R.I., Yamazaki, J. and Hume, J.R. 2000. Lysophosphatidylcholine triggers intracellular calcium release and activation of non-selective cation channels in renal arterial smooth muscle cells. Pflugers. Arch. Eur. J. Physiol. 439: 495-500.
16. Kugiyama, K., Ohgushi, M., Sugiyama, S., Murohara, T., Fukunaga, K., Miyamoto, E. and Yasue, H. 1992. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ. Res. 71: 1422-1428.
17. 2+. Biochem. Biophys. Res. Commun. 165: 312-318.
18. + currents in rabbit coronary myocytes. Am. J. Physiol. 266: C1523-C1537.
19. Lyons, T.J. 1993. Glycanon and oxidation: a role in the pathogenesis of atherosclerosis. Am. J. Cardiol. 71: 26B-31B.
20. Magishi, K., Kimura, J., Kubo, Y. and Abiko, Y. 1996. Exogenous lysophosphatidylcholine increases non-selective cation current in guinea-pig ventricular myocytes. Pflugers. Arch. Eur. J. Physiol. 432: 345-350.
21. McHowat, J., Yamada, K.A., Wu, J., Yan, G.X. and Corr, B.B. 1993. Recent insights pertaining to sarcolemmal phospholipid alterations underlying arrhythmogenesis in the ischemic heart. J. Cardiovasc Electrophysiol. 4: 288-310.
22. Murohara, T., Kugiyama, K., Ohgushi, M., Sugiyama, S., Ohta, Y. and Yasue, H. 1994. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation. Am. J. Physiol. 267: H2441-H2449.
23. Murohara, T., Scalia, R and Lefer, A.M. 1996. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ. Res. 78: 780-789.
24. Nelson, M.T., Patlak, J.B., Worley, J.F. and Standen, N.B. 1990. Calcium channels, potassium channels and voltage dependence of arterial smooth muscle tone. Am. J. Physiol. 259. C3-C18.
25. Ohara, Y., Peterson, E., Zheng, B., Kuo, J.F. and Harrison, D G. 1994. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler. Thromb. 14: 1007-1003.
26. 2+ influx in vascular smooth muscle cells. Am. J. Physiol. 264: C885-C893.
27. Sugiyama, S., Kugiyama, K., Ohgushi, M., Fujimoto, K. and Yasue, H. 1994. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. Circ. Res.74: 565-575.
28. Watson, C.L. and Gold, M.R. 1997. Lysophosphatidylcholine modulates cardiac INa via multiple protein kinase pathways. Circ. Res. 81: 387-395.